Showing 3,221 - 3,240 results of 4,870 for search '"pharmacy"', query time: 0.10s Refine Results
  1. 3221
  2. 3222
  3. 3223
  4. 3224
  5. 3225
  6. 3226
  7. 3227
  8. 3228

    Novel Nanozyme-Based Multicomponent in situ Hydrogels with Antibacterial, Hypoxia-Relieving and Proliferative Properties for Promoting Gastrostomy Tube Tract Maturation by Xiao F, Yan B, Yuan T, He Y, Zhang X, He X, Peng W, Xu Y, Cao J

    Published 2025-01-01
    “…Feng Xiao,1,* Bisong Yan,2,* Tianwen Yuan,2 Yang He,2 Xiaojun Zhang,3 Xiaoyun He,1 Wei Peng,1 Ying Xu,3 Jun Cao1,4 1Shanghai Eighth People’s Hospital, Xuhui District, Shanghai, 200030, People’s Republic of China; 2Department of Interventional Oncology, Dahua Hospital, Xuhui District, Shanghai, 200237, People’s Republic of China; 3College of Pharmacy, Jiangsu University, Zhenjiang, 212013, People’s Republic of China; 4Shanghai University of Medicine and Health Science, Pudong New Area, Shanghai, 201318, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Cao, Shanghai Eighth People’s Hospital, Xuhui District, Shanghai, 200030, People’s Republic of China, Email juncao11@sina.com Ying Xu, College of Pharmacy, Jiangsu University, Zhenjiang, 212013, People’s Republic of China, Email ingyx@sina.com.cnPurpose: Gastrostomy is the commonly used enteral feeding technology. …”
    Get full text
    Article
  9. 3229
  10. 3230
  11. 3231
  12. 3232

    Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database by Liu J, Desai K, Teng CC, Sturm D, Stockbower G, Patadia H, Willey V

    Published 2025-02-01
    “…We wanted to explore how the use of ruxolitinib cream affected the use of other medicines used to treat AD. Using medical and pharmacy insurance records, we found that patients used less of other treatments for AD after starting ruxolitinib cream.Keywords: atopic dermatitis, Janus kinase, ruxolitinib cream, topical…”
    Get full text
    Article
  13. 3233
  14. 3234
  15. 3235
  16. 3236

    Solid Self-Microemulsifying Drug Delivery System for Improved Oral Bioavailability of Relugolix: Preparation and Evaluation by Li ZL, Deng GX, Fang CZ, Zhao YQ, Yuan J, Chen L, Zhong HJ, Guo F

    Published 2025-01-01
    “…Zi-Lin Li,1,* Guo-Xing Deng,1,* Chuan-Zhou Fang,1,* Yue-Qi Zhao,1 Jing Yuan,2 Liang Chen,3 Hai-Jun Zhong,1 Feng Guo1 1School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People’s Republic of China; 2College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471000, People’s Republic of China; 3Jiangxi Prozin Pharmaceutical Co., LTD, Jian, 343100, People’s Republic of China*These authors contributed equally to this workCorrespondence: Feng Guo; Hai-JunZhong, School of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, 330006, People’s Republic of China, Tel +86 0791 86361839, Email fengguo@ncu.edu.cn; zhonghj@ncu.edu.cnPurpose: To improve the oral absorption of relugolix (RLGL), which has low oral bioavailability due to its low solubility and being a substrate of P-glycoprotein (P-gp). …”
    Get full text
    Article
  17. 3237
  18. 3238
  19. 3239
  20. 3240